The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies
JBI Evidence Synthesis · 2026-03 · 24 (3) · 401-408
DOI: 10.11124/jbies-24-00523 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JBI Evidence Synthesis, online erschienen am 10.05.2025. Verfasst von Timothy H Barker und 10 weiteren Autor:innen. Beteiligte Einrichtung: JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 298-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Cross-sectional studies are a useful observational study design that provide a snapshot of a population’s health status at a specific moment in time. Analytical cross-sectional studies are often included in systematic reviews investigating the etiology or risk of diseases, and descriptive cross-sectional studies are often used to determine the prevalence of a disease. As required of all studies that meet eligibility criteria for a systematic review, analytical cross-sectional studies should be subjected to appropriate critical appraisal of their methodological quality to determine the risk of bias. The JBI Effectiveness Methodology Group is currently undertaking a comprehensive revision of the entire suite of JBI critical appraisal tools to align with recent advances in risk of bias assessment. This paper presents the revised critical appraisal tool for risk of bias assessment of analytical cross-sectional studies. Applying tools such as the revised JBI tools within systematic reviews allows end users to make informed decisions using the evidence. We discuss major changes from the previous iterations of this tool and justify these changes within the context of the broader advancements to risk-of-bias assessment science. We also offer practical guidance for the use of this revised tool, and provide examples for interpreting the results of risk-of-bias assessment for analytical cross-sectional studies to support reviewers including these studies in their systematic reviews.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
- Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, The University of Adelaide, Adelaide, SA, Australia.
- Centre for Evidence Based Healthcare, School of Medicine, University of Nottingham, Nottingham UK.
- Queen's Collaboration for Health Care Quality, Queen's University, Kingston, ON, Canada.
- Cochrane Czech Republic, JBI Czech Republic, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
- JBI Center of Evidence-Based Education and Arts Therapies, Faculty of Education, Palacký University Olomouc, Olomouc, Czech Republic.
ORCID-Profile: Sabira Hasanoff
Zitieren
APA
Barker, T. H., Hasanoff, S., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., Klugar, M., Tufanaru, C., Moola, S., Liu, X. L., & Munn, Z. (2026). The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies. JBI Evidence Synthesis, 24(3), 401-408. https://doi.org/10.11124/jbies-24-00523
Vancouver
Barker TH, Hasanoff S, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies. JBI Evidence Synthesis. 2026;24(3):401-408. doi:10.11124/jbies-24-00523
BibTeX
@article{Barker2026,
author = {Barker, Timothy H and Hasanoff, Sabira and Aromataris, Edoardo and Stone, Jennifer C and Leonardi-Bee, Jo and Sears, Kim and Klugar, Miloslav and Tufanaru, Catalin and Moola, Sandeep and Liu, Xian-Liang and Munn, Zachary},
title = {The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies},
journal = {JBI Evidence Synthesis},
year = {2026},
volume = {24},
number = {3},
pages = {401--408},
doi = {10.11124/jbies-24-00523}
}
EUVIMED